Efficiency Assessment of BREFORM. A Multicentric Stepped-wedge Randomized Control Trial.

ConditionSchizophrenia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHôpital le Vinatier

About this trial

In psychiatry, caregiver burden is associated with excess physical and psychological morbidity in relatives of patients with schizophrenic disorders Single or multi-family psychoeducation for caregivers of patients with schizophrenic disorders or first episode psychosis has a direct benefit on the health of the caregiver and an indirect benefit on the health of the ill family member. It is associated with a reduction in the rate of relapse and re-hospitalization and with better compliance with treatment. For single-family psychoeducation, the number of caregivers to be treated to avoid re-hospitalization of the sick family member is 3. For caregivers, psychoeducation is accompanied by an improvement in knowledge of the disorders and coping strategies. Therefore, international recommendations recommend that psychoeducation for caregivers be systematic, early, and integrated into routine care.

Currently, the organization of the French care system does not allow these recommendations to be met. In order to increase the use of psychoeducation in France, early interventions for caregivers must be offered systematically. The effectiveness of early psychoeducation for caregivers needs to be evaluated; only three randomized controlled trials are available in the literature and none have been conducted in France.

Eligibility criteria

Qualifiers

people over 18yo

first-degree relatives (parents, siblings, children) or spouse of the patient

primary caregiver of a patient with schizophrenic disorders or first psychotic episode (DSM5)

consenting to participate to the study

Disqualifiers

mental disorder on Axis I

having already benefited from a family intervention such as psychoeducation

caring for several people with severe psychiatric disorders

receiving income for the caring activities

Trial design

Treatments tested in this trial

  • control group
  • Intervention group

Treatment groups

206 Participants
are divided into 2 treatment groups

Sponsors and collaborators